
Dig for Children's Remains Begins at Irish Home for Unwed Mothers
The circumstances of the children's short lives, the treatment of the mothers and the decades of secrecy surrounding the deaths have been recognized widely as a profound moral stain on the Irish government, which funded the institution, and the Catholic Church, which managed it.
About half of the children, estimated to number about 800 in all, died before their first birthdays.
'Some of the families have been really seeking answers to these questions for many years,' Daniel MacSweeney, who directs the excavation, said in an interview. He leads the Office of the Director of Authorized Intervention, Tuam, an independent organization established by the Irish government in 2022 to recover the remains.
The team began with small motorized diggers, Mr. MacSweeney said, while specialists watched for signs of remains. Once bodies appear, he said, the work will continue by hand, noting 'the complexity of the challenge.'
Scientists estimate that infant bodies lie 'commingled' in the tanks under St. Mary's Mother and Baby Home in Tuam, a town in County Galway in the west of Ireland. The institution was long one of the most notorious homes for unwed mothers in Ireland.
Want all of The Times? Subscribe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
a day ago
- Associated Press
Significant R&D Investments Propel Growth, Declining Sequencing Costs Boost Accessibility and Adoption
DUBLIN--(BUSINESS WIRE)--Jul 31, 2025-- The 'Clinical Next Generation Sequencing (NGS) Market Size, Growth, Share, Trends and Forecasts 2025-2032" report has been added to offering. The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032. Next Generation Sequencing (NGS) has revolutionized the field of genomics, providing unprecedented access to genetic information. This technological advancement facilitates the rapid sequencing of DNA and RNA, enabling a better understanding of various diseases, including cancer and genetic disorders. The global clinical NGS market is experiencing significant growth due to several driving factors. One of the primary drivers of the market is the increasing demand for personalized medicine. As healthcare shifts towards precision interventions, NGS plays a crucial role in tailoring treatments to individual patients based on their genetic profiles. Furthermore, the declining costs associated with sequencing technologies make NGS more accessible to various healthcare facilities, thus expanding its adoption. Significant investments in research and development are also stimulating growth in the global clinical NGS market. Governments and private entities are funneling resources into genomics research, which inevitably leads to innovative NGS applications. Additionally, the urgency to advance diagnostic capabilities to combat infectious diseases has further propelled the demand for NGS solutions. Global Clinical Next Generation Sequencing (NGS) Market Synopsis This new market report presents an in-depth assessment of the global clinical next generation sequencing (NGS) market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global clinical next generation sequencing (NGS) market. The report also provides up-to-date historical market size data for the period 2023-2024 and an illustrative forecast to 2032 covering key market aspects like market value, share, analysis, and trends for the global clinical next generation sequencing (NGS) market. The report provides a detailed analysis of the current industry situation and market requirements, highlighting facts about the market size, market share, revenue for global clinical next generation sequencing (NGS) market segments, and a vivid forecast to 2032. It also provides a comprehensive analysis of the pricing landscape, policies and regulation, and reimbursement pattern by countries and therapy. The report also offers analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report also provides a detailed description of the porter's five forces analysis, SWOT analysis, funding, merger and acquisitions, pipeline, growth drivers and challenges of the global clinical next generation sequencing (NGS) market. The report concludes with the profiles of major market players in the global clinical next generation sequencing (NGS) market. The key market players are evaluated on various parameters such as company overview, technology focus, main competitive advantage, and company initiatives/news of the global clinical next generation sequencing (NGS) market. The report will serve as a source for a 360-degree analysis in which various models will be thoroughly integrated. After a thorough study of the historical and current growth parameters, the growth prospects of the global clinical next generation sequencing (NGS) market are determined with utmost precision. Key Features of the Report Key Questions the Report Addresses List of Key Players in the Global Clinical Next Generation Sequencing (NGS) Market Global Clinical Next Generation Sequencing (NGS) Market: Segmentation Market Segment by Product Type Market Segment by Workflow Market Segment by Application Market Segment by Region For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: ONCOLOGY HEALTH GENETICS GENERAL HEALTH RESEARCH SCIENCE BIOTECHNOLOGY SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 07/31/2025 11:27 AM/DISC: 07/31/2025 11:28 AM
Yahoo
2 days ago
- Yahoo
$1.15 Bn Market to Double by 2032, Fueled by Non-Invasive GI Diagnostics
The global Robotic Capsule Endoscopes (RCEs) Market is set to grow from USD 1.15 billion in 2024 to USD 2.40 billion by 2032, at a CAGR of 9.63%. This growth is due to rising GI tract disorder diagnoses, a demand for non-invasive diagnostics, and advances in AI and capsule technology. Robotic Capsule Endoscopes (RCEs) Market Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Robotic Capsule Endoscopes (RCEs) Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Wireless RCEs, Wired RCEs), By Technology, By Application, By End User" has been added to offering. The global Robotic Capsule Endoscopes (RCEs) market is poised for remarkable growth, with an estimated size of USD 1.15 billion in 2024, projected to reach USD 2.40 billion by 2032 at a CAGR of 9.63%. This surge is driven by the growing adoption of non-invasive diagnostic technologies to treat gastrointestinal (GI) disorders. RCEs represent a transformative advancement, equipped with micro-cameras, sensors, and robotics for controlled navigation and imaging of the GI tract. As manufacturers focus on innovations such as magnetic control systems and AI-based lesion detection, the industry is overcoming traditional limitations. However, challenges like high costs and regulatory complexities persist. Recent market developments spotlight AnX Robotica's magnetically controlled capsule systems introduced in the US, Olympus's prototypes with enhanced imaging capabilities, and Check-Cap's progress in X-ray-based colon imaging capsules. The convergence of these technologies is paving the way for precision diagnostics in GI healthcare. Market dynamics are shaped by several key trends and drivers. The demand for non-invasive procedures and technological advancements in capsule miniaturization are catalysts for growth. On the other hand, the high cost of devices and regulatory hurdles remain barriers. Despite these challenges, companies are making strides in enhancing control systems, integrating AI for real-time diagnostics, and expanding the applications beyond small bowel imaging. The comprehensive market report provides insights into the competition, identifying strategies for increased sales and market share. With input from industry leaders, the report explores the economic impacts, technological advancements, and tailored strategies that are crucial for navigating the evolving RCEs market landscape. Further analysis includes an exploration of consumer preferences, including buying patterns and decision-making factors, coupled with insights into the regulatory environment's influence on industry growth. The RCEs market report is a valuable resource for understanding consumer behavior and navigating economic shifts. Key Highlights of the Report: Global and regional market size projections from 2024 to 2034. Analysis of market segments, trends, and opportunities. Competitive landscape insights, featuring leading companies. Impact of economic factors, supply chain disruptions, and regulatory issues on market dynamics. Comprehensive data on consumer behavior, brand preferences, and buying patterns. Key Questions Addressed: Current and future market size at various levels. Market penetration of different types and applications. Impact of economic trends and geopolitical issues on market forecasts. Regional market opportunities and high-performing products. Key drivers, challenges, and competitive intelligence. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2032 Estimated Market Value (USD) in 2024 $1152 Million Forecasted Market Value (USD) by 2032 $2403.7 Million Compound Annual Growth Rate 9.6% Regions Covered Global Companies Featured Medtronic plc IntroMedic Co., Ltd. CapsoVision, Inc. Check-Cap Ltd. Olympus Corporation AnX Robotica Corp. Jinshan Science & Technology Co., Ltd. RF Co., Ltd. Chongqing Jinshan Science & Technology Group Siemens Healthineers AG Fujifilm Holdings Corporation BodyCap Pentax Medical (HOYA Corporation) OMOM Capsule Endoscopy Jinshan North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Robotic Capsule Endoscopes (RCEs) Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
$1.15 Bn Market to Double by 2032, Fueled by Non-Invasive GI Diagnostics
The global Robotic Capsule Endoscopes (RCEs) Market is set to grow from USD 1.15 billion in 2024 to USD 2.40 billion by 2032, at a CAGR of 9.63%. This growth is due to rising GI tract disorder diagnoses, a demand for non-invasive diagnostics, and advances in AI and capsule technology. Robotic Capsule Endoscopes (RCEs) Market Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Robotic Capsule Endoscopes (RCEs) Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Wireless RCEs, Wired RCEs), By Technology, By Application, By End User" has been added to offering. The global Robotic Capsule Endoscopes (RCEs) market is poised for remarkable growth, with an estimated size of USD 1.15 billion in 2024, projected to reach USD 2.40 billion by 2032 at a CAGR of 9.63%. This surge is driven by the growing adoption of non-invasive diagnostic technologies to treat gastrointestinal (GI) disorders. RCEs represent a transformative advancement, equipped with micro-cameras, sensors, and robotics for controlled navigation and imaging of the GI tract. As manufacturers focus on innovations such as magnetic control systems and AI-based lesion detection, the industry is overcoming traditional limitations. However, challenges like high costs and regulatory complexities persist. Recent market developments spotlight AnX Robotica's magnetically controlled capsule systems introduced in the US, Olympus's prototypes with enhanced imaging capabilities, and Check-Cap's progress in X-ray-based colon imaging capsules. The convergence of these technologies is paving the way for precision diagnostics in GI healthcare. Market dynamics are shaped by several key trends and drivers. The demand for non-invasive procedures and technological advancements in capsule miniaturization are catalysts for growth. On the other hand, the high cost of devices and regulatory hurdles remain barriers. Despite these challenges, companies are making strides in enhancing control systems, integrating AI for real-time diagnostics, and expanding the applications beyond small bowel imaging. The comprehensive market report provides insights into the competition, identifying strategies for increased sales and market share. With input from industry leaders, the report explores the economic impacts, technological advancements, and tailored strategies that are crucial for navigating the evolving RCEs market landscape. Further analysis includes an exploration of consumer preferences, including buying patterns and decision-making factors, coupled with insights into the regulatory environment's influence on industry growth. The RCEs market report is a valuable resource for understanding consumer behavior and navigating economic shifts. Key Highlights of the Report: Global and regional market size projections from 2024 to 2034. Analysis of market segments, trends, and opportunities. Competitive landscape insights, featuring leading companies. Impact of economic factors, supply chain disruptions, and regulatory issues on market dynamics. Comprehensive data on consumer behavior, brand preferences, and buying patterns. Key Questions Addressed: Current and future market size at various levels. Market penetration of different types and applications. Impact of economic trends and geopolitical issues on market forecasts. Regional market opportunities and high-performing products. Key drivers, challenges, and competitive intelligence. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2032 Estimated Market Value (USD) in 2024 $1152 Million Forecasted Market Value (USD) by 2032 $2403.7 Million Compound Annual Growth Rate 9.6% Regions Covered Global Companies Featured Medtronic plc IntroMedic Co., Ltd. CapsoVision, Inc. Check-Cap Ltd. Olympus Corporation AnX Robotica Corp. Jinshan Science & Technology Co., Ltd. RF Co., Ltd. Chongqing Jinshan Science & Technology Group Siemens Healthineers AG Fujifilm Holdings Corporation BodyCap Pentax Medical (HOYA Corporation) OMOM Capsule Endoscopy Jinshan North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Robotic Capsule Endoscopes (RCEs) Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900